NDRA · Company research
ENDRA Life Sciences Inc. Common Stock (NDRA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 6.06 | $14,356,513.8 | 12616570.8 | 96.6666666666666667 | — | — | — | 2.2753117070233709 | 10.97412413097235546143 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.